Aethlon Medical Corp (AEMD): Enterprise Value to EBITDA Ratio
Aethlon Medical (AEMD) is protected by exclusive patents for blood purification of tumor markers and viruses under strict FDA control. The EV/EBITDA metric on GURU.Markets, which stands at 0.00, confirms the business status. While a team of talented engineers is dedicated to the mission of saving lives, the costs of clinical trials are depleting capital, forcing the company to attract new investors.
Comprehensive metric breakdowns and analytics for aethlonmedical.com (AEMD)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Aethlon Medical|AEMD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aethlon Medical, Inc.|AEMD - Company Total Debt|Debts to Book Capitalization Aethlon Medical Corp|AEMD - Long-Term Debt|Company Short-Term Debts Aethlon Medical|Quick Ratio aethlonmedical.com
- financial results and valuation multiples details:
AEMD - Net Financial Result|Projected Future Earnings Aethlon Medical|AEMD - Price to Earnings Ratio|Forward P/E Multiple Aethlon Medical|AEMD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aethlon Medical Corp|AEMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Aethlon Medical|AEMD - Earnings per share for the trailing year|Quarterly EPS earnings growth aethlonmedical.com|AEMD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Aethlon Medical
Analysis of all company metrics:Aethlon AEMD
This indicator correlates the total enterprise value, including net debt, with operating profit, allowing for an assessment of capital protection against excessive leverage. For Aethlon Medical (AEMD), which is currently in the clinical trial stage for the Hemopurifier and has no current revenue, this metric reflects the cost of awaiting FDA approval. Analyzing the EV/EBITDA value for Aethlon Medical (AEMD) helps determine the depth of the valuation drawdown and balance the risk of missed profits with a conservative approach to capital.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio STRATA Skin (SSKN)|EV/EBITDA Multiple GCTK|NAOV - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Venus Concept VERO|NUWE: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|cutera.com (CUTR) - EV/EBITDA Multiple|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|Enterprise Value to Operating Income Before Depreciation Ratio RSLS|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
